{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:22:15Z","timestamp":1795022535065,"version":"4.10.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Jiangsu Provincial Science and Technology Plan Project","award":["BE2022743"],"award-info":[{"award-number":["BE2022743"]}]},{"name":"Changchun City and Chinese Academy of Sciences Cooperation Project","award":["22SH16"],"award-info":[{"award-number":["22SH16"]}],"id":[{"id":"https:\/\/ror.org\/034t30j35","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Suzhou Science and Technology Plan Project","award":["SJC2022013"],"award-info":[{"award-number":["SJC2022013"]}]},{"name":"Suzhou Medical Key Discipline Project","award":["SZXK202118"],"award-info":[{"award-number":["SZXK202118"]}]},{"name":"Suzho Youth Science \u00ef\u00bc\u0086Technol Project","award":["KJXW2022057"],"award-info":[{"award-number":["KJXW2022057"]}]},{"name":"Gusu Talent Program","award":["GSWS2023032;\u00ef\u00bc\u00882023\u00ef\u00bc\u0089035"],"award-info":[{"award-number":["GSWS2023032;\u00ef\u00bc\u00882023\u00ef\u00bc\u0089035"]}]},{"name":"Suzhou Science and Technology Plan Project","award":["SKY2023077; GWZX202303"],"award-info":[{"award-number":["SKY2023077; GWZX202303"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,24]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Platelet transfusions are the key treatment for patients with severely low platelet counts and significant bleeding symptoms. Platelet transfusion refractorines (PTR) is defined as unsatisfactory transfusion of platelets with at least 2 ABO blood groups matched and stored for &lt;72 hours.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 37-year-old woman presented for medical evaluation due to the cessation of fetal heart activity after 50 days of gestation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>AML-M2, PTR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>To explore potential immune-mediated causes of platelet refractoriness, the following diagnostic evaluations were conducted: Platelet antibody screening using the PAK-Lx assay (Immucor) to detect anti-HLA class I and HPA antibodies. Anti-HLA class I specificity determination via LIFECODES LSA Single Antigen bead assays (Luminex). Molecular typing of HLA class I and HPA alleles using PCR-sequence based typing (PCR-SBT), as well as CD36 phenotyping via flow cytometry. Confirmation testing for anti-HPA-5b antibodies using chloroquine-treated platelet solid-phase assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The patient had high-fluorescence-intensity HLA antibodies along with HPA antibodies, resulting in severe refractoriness to platelet transfusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Various methods were used to comprehensively analyze the specificity of anti-platelet antibodies in the samples of patients with ineffective platelet transfusion, thus providing a reference for the clinical diagnosis and treatment of PTR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000044945","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T19:01:12Z","timestamp":1761332472000},"page":"e44945","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Marked platelet transfusion refractoriness caused by anti-HLA-I and anti-HPA-5b antibodies: A case report"],"prefix":"10.1097","volume":"104","author":[{"given":"Yihan","family":"Wang","sequence":"first","affiliation":[{"name":"Suzhou Blood Center, Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[{"name":"Suzhou Blood Center, Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengbao","family":"Duan","sequence":"additional","affiliation":[{"name":"Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, Jiangsu, China, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Jin","sequence":"additional","affiliation":[{"name":"Suzhou Blood Center, Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Wang","sequence":"additional","affiliation":[{"name":"Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, Jiangsu, China, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujue","family":"Wang","sequence":"additional","affiliation":[{"name":"Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, Jiangsu, China, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longhai","family":"Tang","sequence":"additional","affiliation":[{"name":"Suzhou Blood Center, Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2519-1176","authenticated-orcid":false,"given":"Mingyuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Suzhou Blood Center, Suzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261118","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s002770050280","article-title":"Frequency and causes of refractoriness in multiply transfused patients.","volume":"74","author":"Legler","year":"1997","journal-title":"Ann Hematol"},{"key":"R2-20261118","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/trf.14316","article-title":"How do I \u2026 manage the platelet transfusion-refractory patient?","volume":"57","author":"Juskewitch","year":"2017","journal-title":"Transfusion"},{"key":"R3-20261118","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2141.2007.06753.x","article-title":"Platelet refractoriness due to combined anti-HLA and anti-HPA-5a alloantibodies: clinical management during myeloablative allogeneic HSCT and development of a quantitative MAIPA assay.","volume":"139","author":"Arber","year":"2007","journal-title":"Br J Haematol"},{"key":"R4-20261118","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1399-0039.2012.01852.x","article-title":"HLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention and management.","volume":"79","author":"Pavenski","year":"2012","journal-title":"Tissue Antigens"},{"key":"R5-20261118","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients.","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"key":"R6-20261118","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/trf.12509","article-title":"A new bead-based human platelet antigen antibodies detection assay versus the monoclonal antibody immobilization of platelet antigens assay.","volume":"54","author":"Porcelijn","year":"2013","journal-title":"Transfusion"},{"key":"R7-20261118","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tmrv.2016.12.001","article-title":"Platelet immunology in China: research and clinical applications.","volume":"31","author":"Wu","year":"2016","journal-title":"Transfus Med Rev"},{"key":"R8-20261118","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12288-022-01547-9","article-title":"Methodological study on the establishment of HLA\/HPA gene bank of platelet donors and its clinical application.","volume":"39","author":"Xu","year":"2022","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R9-20261118","doi-asserted-by":"crossref","first-page":"e29268","DOI":"10.1016\/j.heliyon.2024.e29268","article-title":"Establishment and clinical application of the HLA genotype database of platelet-apheresis donors in Suzhou.","volume":"10","author":"He","year":"2024","journal-title":"Heliyon"},{"key":"R10-20261118","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1515\/cclm-2014-1037","article-title":"Comparison of the bead-based simultaneous analysis of specific platelet antibodies assay (SASPA) and Pak Lx Luminex technology with the monoclonal antibody immobilization of platelet antigens assay (MAIPA) to detect platelet alloantibodies.","volume":"53","author":"Rockenbauer","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"R11-20261118","first-page":"380","article-title":"Advances in alloimmune thrombocytopenia: perspectives on current concepts of human platelet antigens, antibody detection strategies, and genotyping.","volume":"13","author":"Hayashi","year":"2015","journal-title":"Blood Transfus"},{"key":"R12-20261118","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ajcp\/aqy121","article-title":"HLA-mediated platelet refractoriness.","volume":"151","author":"Schmidt","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"R13-20261118","first-page":"806","article-title":"Human platelet alloantigens.","volume":"113","author":"Santoso","year":"2001","journal-title":"Wien Klin Wochenschr"},{"key":"R14-20261118","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3324\/haematol.2011.056556","article-title":"Platelet adhesion to decorin but not collagen I correlates with the integrin \u03b12 dimorphism E534K, the basis of the human platelet alloantigen (HPA)-5 system.","volume":"97","author":"Kunicki","year":"2012","journal-title":"Haematologica"},{"key":"R16-20261118","doi-asserted-by":"crossref","first-page":"112868","DOI":"10.1016\/j.jim.2020.112868","article-title":"Application of lyophilised human platelets for antibody detection in solid phase red cell adherence assay.","volume":"487","author":"Duan","year":"2020","journal-title":"J Immunol Methods"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044945","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:01:06Z","timestamp":1795021266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":15,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044945","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"2025-02-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}